Chemours Co. (NYSE:CC) has earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $14.79.

A number of research firms have commented on CC. Zacks Investment Research cut shares of Chemours from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 1st. TheStreet raised shares of Chemours from a “sell” rating to a “hold” rating in a research report on Tuesday, August 9th. Jefferies Group reaffirmed a “hold” rating and set a $17.00 price objective (up from $15.00) on shares of Chemours in a research report on Thursday, November 10th. Citigroup Inc. reduced their price objective on shares of Chemours from $11.00 to $9.00 and set a “neutral” rating for the company in a research report on Thursday, August 11th. Finally, Argus raised shares of Chemours from a “hold” rating to a “buy” rating and set a $13.00 price objective for the company in a research report on Wednesday, August 10th. They noted that the move was a valuation call.

A number of large investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Chemours by 11.9% in the second quarter. Vanguard Group Inc. now owns 15,430,215 shares of the company’s stock valued at $127,146,000 after buying an additional 1,643,003 shares in the last quarter. BlackRock Fund Advisors boosted its stake in Chemours by 7.7% in the third quarter. BlackRock Fund Advisors now owns 13,116,695 shares of the company’s stock valued at $209,867,000 after buying an additional 934,559 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its stake in Chemours by 0.7% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 4,613,843 shares of the company’s stock valued at $73,821,000 after buying an additional 31,548 shares in the last quarter. State Street Corp boosted its stake in Chemours by 37.8% in the second quarter. State Street Corp now owns 4,027,367 shares of the company’s stock valued at $33,185,000 after buying an additional 1,105,122 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in Chemours by 6.4% in the third quarter. Bank of New York Mellon Corp now owns 2,705,801 shares of the company’s stock valued at $43,294,000 after buying an additional 163,893 shares in the last quarter. 76.65% of the stock is owned by institutional investors and hedge funds.

Shares of Chemours (NYSE:CC) traded down 0.32% during midday trading on Wednesday, hitting $21.95. 2,145,185 shares of the company were exchanged. Chemours has a one year low of $3.06 and a one year high of $22.22. The company has a 50-day moving average of $16.57 and a 200 day moving average of $11.85. The company has a market capitalization of $3.99 billion, a P/E ratio of 26.57 and a beta of 3.09.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Thursday, November 17th will be given a $0.03 dividend. The ex-dividend date is Tuesday, November 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.54%. Chemours’s payout ratio is presently 14.81%.

About Chemours

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.

5 Day Chart for NYSE:CC

Receive News & Stock Ratings for Chemours Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Co. and related stocks with our FREE daily email newsletter.